ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marvin Pomerantz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pomerantz, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pomerantz, M.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;64:224-225
© 1997 The Society of Thoracic Surgeons

Invited Commentary

Invited Commentary

Marvin Pomerantz, MD

General Thoracic Surgery Section, Division of Cardiothoracic Surgery, University of Colorado Health Sciences Center, 4200 E 9th Ave, #C310

The first 20% of the full text of this article appears below.

See also page 220.

Doctor Massard and his colleagues should be complimented on their fine report on a disease process that should disappear by the law of natural attrition. This article most likely represents the last large series concerning long-term complications of extraperiosteal plombage therapy using translucent methyl . . . [Full Text of this Article]


Related Article

Long-Term Complications of Extraperiosteal Plombage
Gilbert Massard, Pascal Thomas, Pierre Barsotti, Pierre Riera, Roger Giudicelli, Eugène Reboud, Georges Morand, Pierre A. Fuentes, and Jean-Marie Wihlm
Ann. Thorac. Surg. 1997 64: 220-225. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.